Try our Advanced Search for more refined results
Life Sciences - June, 2004
22 articles
- Appeals Court Reinstates Antitrust Suit Over Taxol Generics
- Australian Panel Calls For Copyright Amendments
- Federal Circuit Remands Immunomedics Suit Vs. Cytogen
- Schwarz Pharma To Pay $50M To Settle Patent Suit Over Prilosec
- Mylan Sues FDA For Delaying Duragesic Generic
- Kirin Settles Suit Vs. Geron Over Cancer Vaccine Development Rights
- Lumenis To Pay Palomar $4.1M To Settle Patent Suit
- Court Consolidates Kos Suits Vs. Barr Over Niaspan Patents
- Inamed Pays $17.2M To Settle Patent Dispute With Ethicon
- Biotech Patenting Down, Lawsuits Up, Report Finds
- Energizer Countersues Gillette Over Diamond Coating Patents
- Botox Maker Wins Trademark Suit Over Anti-Wrinkle Treatment
- Jenner & Block Absorbs Roper & Quigg, Doubles IP Practice
- Andrx To Pay $6M To Settle Kos Trademark Suit
- Court Bans Smith & Nephew Surgical Devices in ArthroCare Patent Dispute
- Judge Rules For Andrx In Bristol-Myers Patent Suit Over Monopril
- Valeant Pulls Appeal Of Patent Suit Vs. Three Rivers, Par Pharma
- Reliant Challenges Abbott's TriCor Patents
- Supreme Court Mulls Review Of Case On Antitrust Law In Drug Patent Settlements
- Roche Asks Court To Declare Enzo Patent Invalid
- Inamed Sues Medicis Over Anti-Wrinkle Patent
- Federal Circuit Says Cordis Likely To Prevail In Patent Case Vs. Boston Scientific